Design and In vivo Evaluation of Palonosetron HCl Mouth Dissolving Films in the Management of Chemotherapy-Induced Vomiting

DOI:

https://doi.org/10.37285/ijpsn.2017.10.6.9

Authors

  • Y. Srinivasa Rao
  • K. Adinarayana Reddy

Abstract

Fast dissolving oral delivery systems are solid dosage forms, which disintegrate or dissolve within 1 minute in the mouth without drinking water or chewing. Mouth dissolving film (MDF) is a better alternate to oral disintegrating tablets due to its novelty, ease of use and the consequent patient compliance. The purpose of this work was to develop mouth dissolving oral films of palonosetron HCl, an antiemetic drug especially used in the prevention and treatment of chemotherapy-induced nausea and vomiting. In the present work, the films were prepared by using solvent casting method with various polymers HPMC E3, E5 & E15 as a film base synthetic polymer, propylene glycol as a plasticizer and maltodextrin and other polymers. Films were found to be satisfactory when evaluated for thickness, in vitro drug release, folding endurance, drug content and disintegration time. The surface pH of all the films was found to be neutral. The in vitro drug release of optimized formulation F29 was found to be 99.55 ± 6.3 7% in 7 min. The optimized formulation F29 also showed satisfactory surface pH, drug content (99.38 ± 0.08 %), disintegration time of 8 seconds and good stability. FTIR data revealed that no interaction takes place between the drug and polymers used in the optimized formulation. In vitro and in vivo evaluation of the films confirmed their potential as an innovative dosage form to improve delivery and quick onset of action of Palonosetron Hydrochloride. Therefore, the mouth dissolving film of palonosetron is potentially useful for the treatment of emesis disease where quick onset of action is desired, also improved patient compliance.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Palonosetron, mouth dissolving films, chemotherapy, disintegration time, vomiting

Downloads

Published

2017-11-30

How to Cite

1.
Rao YS, Reddy KA. Design and In vivo Evaluation of Palonosetron HCl Mouth Dissolving Films in the Management of Chemotherapy-Induced Vomiting. Scopus Indexed [Internet]. 2017 Nov. 30 [cited 2024 Dec. 11];10(6):3929-36. Available from: https://www.ijpsnonline.com/index.php/ijpsn/article/view/876

Issue

Section

Research Articles

References

Aditya D and Mangal N (2008). Formulation and Evaluation of Fast Dissolving Films for Delivery of Triclosan to the Oral Cavity. AAPS Pharm Sci Tech 9: 349
Agarwal GP, Seth AK, and Saini TR (1985). Evaluation of free films. Ind Drugs 23: 45-7.
Aggarwal J, Singh G, Saini S, and Rana AC (2011). Fast dissolving films: A novel approach to oral drug delivery. Int Res J of Phar 2: 69-74.
Dinge A and Nagarsenker M (2012). Formulation and evaluation of fast dissolving films for delivery of triclosan to the oral cavity. AAPS Pharm Sci Tech. 9(2): 349-56.
Hiroyoshi S, Kazumi T, Misao N, Katsuhiko M, Tadao T, Hirotaka Y, Naoki I, Kazuyuki H, Mayumi Y, Yasutomi K, and Yoshinori I (2009). Preparation of a fast dissolving oral thin film containing dexamethasone: A possible application to antiemesis during cancer chemotherapy. Eur J Pharm Biopharm 73(3): 361-5.
Janaki Pathi P and Appala Raju N (2012). The Estimation of Palonosetron Hydrochloride in Parenterals by RPHPLC. Asian J Pharm Tech 2(2):77-79.
Kai BL, Yvonne TFT and Kok KP (2012). Characterization of Oral Disintegrating Film Containing Donepezil for Alzheimer Disease. AAPS Pharm Sci Tech 13: 1-3.
Klancke J (2003). Dissolution testing of orally disintegrating tablets. Dissol Technol 10: 6-8.
Kumar GV, Krishna RV, William GJ, and Konde A (2005). Formulation and evaluation of buccal films of salbutamol sulphate. Indian J Pharm Sci 67: 160-4.
Liang AC and Chen LH (2001). Fast dissolving intraoral drug delivery systems. Exp Opin Ther Patents 11: 981-6.
Mona N, Mayank N, and Vikram C (2012). Formulation and evaluation of mouth dissolving film of antipsychotic drug aripiprazole. Der Phar Lett 4(4): 1221-1227.
Nafee NA, Boraie MA, Ismail FA, and Mortad LM (2003). Design and characterization of mucoadhesive buccal patches containing cetyl pyridinium chloride. Acta Pharm. 53: 199-212.
Parakh SR and Gothoskar AV (2003). Review of mouth dissolving tablet technologies. Pharm Tech 27: 92-100.
Peh KK and Wong FC (1999). Polymeric films as vehicle for buccal Delivery: Swelling, mechanical and bioadhesive properties. J Pharm Sci 2: 53-61.
Ponchel A (1993). Formulation of oral mucosal drug delivery systems for the systemic delivery of bioactive materials. Adv Drug Deli Rev 13: 1-2.
Prabhakara P, Ravi M, Marina K, Vijaynarayana K, Ullas Souza D, Harish NM and Shastry CS (2011). Formulation and evaluation of fast dissolving films of levocetirizine dihydrochloride. Int J Pharm Inves 1(2): 99-104.
Smart JD (2005). Buccal drug delivery. Expert Opin Drug Deliv 2: 507-517.
Tanwar YS, Chauhan CS and Sharma A (2007). Development and evaluation of carvedilol transdermal patches. Acta Pharm 57: 151-59.
Tintinalli Judith E (2010). Emergency Medicine: A Comprehensive Study Guide (Emergency Medicine (Tintinalli)). NewYork: McGraw-Hill Companies. 830.